Related Experiment Video
Updated: Sep 27, 2025

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
Lyso-PAF, a biologically inactive phospholipid, contributes to RAF1 activation
Xue Gao1, Yijie Liu2, Yuancheng Li3
1Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA; Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Phospholipase A2 group VII (PLA2G7) is crucial for melanoma cell proliferation and tumor growth, particularly in NRAS-mutant cancers. It signals via Lyso-PAF to activate RAF1, a pathway distinct from BRAF V600E mutations.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Phospholipase A2 group VII (PLA2G7) is known as a plasma enzyme involved in inflammatory response.
- Its role in intracellular signaling pathways, particularly in cancer, remains less understood.
Purpose of the Study:
- To investigate the intracellular functions of PLA2G7 in melanoma cell proliferation and tumor growth.
- To elucidate the signaling mechanisms by which PLA2G7 influences cancer cell growth, focusing on the RAS-RAF1 pathway.
Main Methods:
- Utilized melanoma cell lines with specific mutations (NRAS, BRAF V600E, KRAS).
- Investigated the role of PLA2G7 and its product Lyso-PAF in cell proliferation and tumor growth.
- Analyzed the activation of RAF1 and associated kinases (PAK1, PAK2) using biochemical assays.
- Examined signaling in response to epidermal growth factor (EGF) stimulation.
Main Results:
- Intracellular PLA2G7 is essential for the proliferation and tumor growth of NRAS-mutant melanoma cells, but not BRAF V600E-mutant cells.
- PLA2G7 signals through Lyso-PAF to activate RAF1 in NRAS-mutant cells, a mechanism bypassed by BRAF V600E.
- Lyso-PAF activates p21-activated kinase 2 (PAK2), which contributes to RAF1 phosphorylation.
- The PLA2G7-PAK2 pathway is also critical for RAF1 activation stimulated by EGF or in KRAS-mutant cancer cells.
Conclusions:
- PLA2G7 and its product Lyso-PAF possess significant intracellular signaling functions.
- They act as key mediators in the RAS-RAF1 signaling pathway, impacting cell proliferation and tumor growth.
- This highlights a potential therapeutic target in specific cancer types driven by RAS mutations.
Related Concept Videos
MAPK Signaling Cascades
Mechanism of Filopodia Formation
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
cAMP-dependent Protein Kinase Pathways
The JAK-STAT Signaling Pathway
RNA Polymerase II Accessory Proteins

